Related Experiment Video
Updated: Jul 2, 2026

Nine-Grid Area Division Method: A New Ideal Bone Puncture Region for Percutaneous Vertebroplasty in Lumbar Spine
Published on: August 9, 2024
Frequency and outcome of pulmonary polymethylmethacrylate embolism during percutaneous vertebroplasty
A Venmans1, P N M Lohle, W J van Rooij
1Department of Radiology, St. Elisabeth Ziekenhuis, Tilburg, the Netherlands.
Background And Purpose:
During percutaneous polymethylmethacrylate (PMMA) vertebroplasty (PV), PMMA cement may migrate into the venous system and subsequently be transported to the pulmonary arteries. Frequency, outcome, and imaging findings of PMMA pulmonary embolism are poorly understood. We retrospectively assessed the frequency and outcome of PMMA embolism during PV in a large patient cohort and evaluated the relationship of the volume of injected PMMA to the occurrence of pulmonary PMMA embolism.
Materials And Methods:
Between 2001 and 2007, 532 osteoporotic compression fractures in 299 consecutive patients were treated with PV. PMMA embolism was defined as venous PMMA migration toward the lungs visible on biplane fluoroscopy during PV. CT was performed immediately and 1 year after PMMA migration.
Results:
Venous PMMA migration occurred during 11 PVs in 11 patients (2.1%, 95% confidence interval, 1.1-3.7%). CT in 8 patients demonstrated small peripheral pulmonary PMMA emboli. All 11 patients remained asymptomatic during 1-year follow-up. Repeat CT scanning after 1 year in 6 patients demonstrated unchanged pulmonary PMMA deposits without late reactive changes. Mean injected cement volume in patients with and without PMMA embolism was not different (3.6 +/- 1.06 mL versus 3.3 +/- 1.16 mL, P = .43). Similar comparison for thoracic and thoracolumbar vertebrae yielded P values of .07 and .9.
Conclusion:
Pulmonary PMMA embolism during PV is an infrequent complication without permanent clinical sequelae. After 1 year, no pulmonary reaction was seen on CT. No definite relationship of PMMA emboli with injected cement volume could be established.
Insights
Pulmonary embolism from polymethylmethacrylate (PMMA) cement during percutaneous vertebroplasty (PV) is rare and asymptomatic. Follow-up CT scans show no lasting pulmonary changes, indicating a low risk for patients undergoing PV.
Area of Science:
- Interventional Radiology
- Pulmonary Medicine
- Biomaterials Science
Background:
- Percutaneous vertebroplasty (PV) uses polymethylmethacrylate (PMMA) cement to treat osteoporotic compression fractures.
- PMMA cement can migrate into the venous system, potentially causing pulmonary embolism.
- The frequency, outcomes, and imaging characteristics of PMMA pulmonary embolism are not well understood.
Purpose of the Study:
- To assess the frequency and clinical outcomes of PMMA pulmonary embolism following PV.
- To evaluate the relationship between injected PMMA volume and the occurrence of pulmonary embolism.
- To characterize imaging findings of pulmonary PMMA embolism on CT scans.
Main Methods:
- Retrospective analysis of 532 PV procedures in 299 patients (2001-2007).
- Definition of PMMA embolism: venous migration of PMMA toward the lungs, visualized on fluoroscopy.
- Immediate and 1-year follow-up CT scans were performed for patients with PMMA migration.
Main Results:
- PMMA embolism occurred in 2.1% of PV procedures (11 patients).
- CT revealed small peripheral pulmonary PMMA emboli in 8 patients; all remained asymptomatic.
- No significant difference in injected cement volume was found between patients with and without embolism. 1-year CT showed no reactive changes.
Conclusions:
- Pulmonary PMMA embolism is an infrequent complication of PV.
- The complication appears to have no permanent clinical sequelae.
- No association was found between injected cement volume and PMMA emboli, and no pulmonary reactions were observed on CT after 1 year.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pneumothorax-II
Clinical Manifestations:
